Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. (Q38315868)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2000

Language	Label	Description	Also known as
English	Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.	scientific article published on February 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

based on heuristic

inferred from title

Gabriella Pagnan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Fabio Pastorino

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lizzia Raffaghello

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

D D Stuart

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P G Montaldo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T M Allen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B Calabretta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Ponzoni

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

253-261

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655443%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

"Megatherapy" for advanced neuroblastoma--rationale and role.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Clinical strategies for the treatment of neuroblastoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Acute leukemia viruses E26 and avian myeloblastosis virus have related transformation-specific RNA sequences but different genetic structures, gene products, and oncogenic properties

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Fate of cationic liposomes and their complex with oligonucleotide in vivo

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

The protein encoded by the human proto-oncogene c-myc

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Brain drug delivery of small molecules using immunoliposomes

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated Fenretinide

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.3.253

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38315868&oldid=1612318833"